Tag: Human Papillomavirus (HPV)
HPV Cervical CA Screening Cuts Odds of Later CIN3+ Diagnosis
Use of primary HPV testing results in significantly lower odds of CIN3+ compared with cytology testing
Parents Say Cancer Prevention Best Reason for HPV Vaccination
Findings based on large survey of parents to assess best, worst reasons for vaccination
Older Adults Increasingly Have HPV+ Oropharyngeal Cancers
Regardless of age, favorable survival conferred by an HPV-positive tumor status
NCI Cancer Centers Endorse Goal of Eliminating HPV Cancers
HPV vaccine, screening offer opportunity to prevent 12,000 cervical CAs, 40,000 HPV-linked CAs/year
Addressing Parents’ HPV Vaccine Hesitancy Ups Vaccination Rates
More adolescents receive HPV vaccination same day with physician engagement versus acquiescence
Good Evidence That HPV Vaccines Protect Against Cervical Precancer
High-certainty evidence for protection in adolescent girls and young women aged 15 to 26 years
mRNA Assay Less Sensitive Than DNA Assay for Latent HPV
A 69.3 percent difference was seen in HPV mRNA results compared with previous HPV DNA results
Bundled Intervention May Improve HPV Vaccination Rates
Intervention included QI training, provider prompts, communication training, performance feedback
HPV Vaccine Intervention Tied to Increased Vaccination
Clinician intervention includes communication training, fact sheets, parent education site
HPV Prevalence 4.9 Percent in Tonsil Tissue of Healthy Adults
Human papillomavirus colocalizes to the biofilm of the tonsillar crypts
